
Alana Harris Dent
Examiner (ID: 7014)
| Most Active Art Unit | 1643 |
| Art Unit(s) | 1643, 1642 |
| Total Applications | 1512 |
| Issued Applications | 526 |
| Pending Applications | 351 |
| Abandoned Applications | 660 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5672506
[patent_doc_number] => 20060177861
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-10
[patent_title] => 'Novel compositions and methods in cancer associated with altered expression of MCM3AP'
[patent_app_type] => utility
[patent_app_number] => 11/357638
[patent_app_country] => US
[patent_app_date] => 2006-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 23122
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0177/20060177861.pdf
[firstpage_image] =>[orig_patent_app_number] => 11357638
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/357638 | Novel compositions and methods in cancer associated with altered expression of MCM3AP | Feb 16, 2006 | Abandoned |
Array
(
[id] => 4778201
[patent_doc_number] => 20080286199
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-20
[patent_title] => 'Methods of Detecting Ovarian Cancer'
[patent_app_type] => utility
[patent_app_number] => 11/883103
[patent_app_country] => US
[patent_app_date] => 2006-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10501
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20080286199.pdf
[firstpage_image] =>[orig_patent_app_number] => 11883103
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/883103 | Methods of detecting ovarian cancer | Feb 15, 2006 | Issued |
Array
(
[id] => 5776746
[patent_doc_number] => 20060105386
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-18
[patent_title] => '17867, a novel human aminopeptidase'
[patent_app_type] => utility
[patent_app_number] => 11/333838
[patent_app_country] => US
[patent_app_date] => 2006-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 24997
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20060105386.pdf
[firstpage_image] =>[orig_patent_app_number] => 11333838
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/333838 | 17867, a novel human aminopeptidase | Jan 16, 2006 | Abandoned |
Array
(
[id] => 5777556
[patent_doc_number] => 20060106196
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-18
[patent_title] => 'Antigenic peptides derived from telomerase'
[patent_app_type] => utility
[patent_app_number] => 11/332378
[patent_app_country] => US
[patent_app_date] => 2006-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8501
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0106/20060106196.pdf
[firstpage_image] =>[orig_patent_app_number] => 11332378
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/332378 | Antigenic peptides derived from telomerase | Jan 16, 2006 | Issued |
Array
(
[id] => 5785230
[patent_doc_number] => 20060204982
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-14
[patent_title] => 'Novel compositions and methods for cancer'
[patent_app_type] => utility
[patent_app_number] => 11/330726
[patent_app_country] => US
[patent_app_date] => 2006-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24859
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20060204982.pdf
[firstpage_image] =>[orig_patent_app_number] => 11330726
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/330726 | Novel compositions and methods for cancer | Jan 11, 2006 | Abandoned |
Array
(
[id] => 5760070
[patent_doc_number] => 20060211015
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-21
[patent_title] => 'Novel compositions and methods for cancer'
[patent_app_type] => utility
[patent_app_number] => 11/330648
[patent_app_country] => US
[patent_app_date] => 2006-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32585
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0211/20060211015.pdf
[firstpage_image] =>[orig_patent_app_number] => 11330648
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/330648 | Novel compositions and methods for cancer | Jan 11, 2006 | Abandoned |
Array
(
[id] => 4933580
[patent_doc_number] => 20080004355
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-03
[patent_title] => 'Method for Inhibiting Telomerase Activity and an Agent for Inhibiting the Same'
[patent_app_type] => utility
[patent_app_number] => 11/793959
[patent_app_country] => US
[patent_app_date] => 2005-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 21269
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20080004355.pdf
[firstpage_image] =>[orig_patent_app_number] => 11793959
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/793959 | Method for Inhibiting Telomerase Activity and an Agent for Inhibiting the Same | Dec 26, 2005 | Abandoned |
Array
(
[id] => 5289978
[patent_doc_number] => 20090022708
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-22
[patent_title] => 'Trefoil Factors and Methods of Treating Proliferation Disorders Using Same'
[patent_app_type] => utility
[patent_app_number] => 11/794025
[patent_app_country] => US
[patent_app_date] => 2005-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 18129
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20090022708.pdf
[firstpage_image] =>[orig_patent_app_number] => 11794025
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/794025 | Trefoil Factors and Methods of Treating Proliferation Disorders Using Same | Dec 21, 2005 | Abandoned |
Array
(
[id] => 5748364
[patent_doc_number] => 20060111296
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-25
[patent_title] => 'Plasmin-inhibitory therapies'
[patent_app_type] => utility
[patent_app_number] => 11/287121
[patent_app_country] => US
[patent_app_date] => 2005-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 17759
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20060111296.pdf
[firstpage_image] =>[orig_patent_app_number] => 11287121
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/287121 | Plasmin-inhibitory therapies | Nov 21, 2005 | Abandoned |
Array
(
[id] => 6228850
[patent_doc_number] => 20100183588
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-22
[patent_title] => 'Mutated Netrin-4, Fragments Thereof And Their Use As Medicines'
[patent_app_type] => utility
[patent_app_number] => 11/791274
[patent_app_country] => US
[patent_app_date] => 2005-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 37459
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20100183588.pdf
[firstpage_image] =>[orig_patent_app_number] => 11791274
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/791274 | Mutated netrin-4, fragments thereof and their use as medicines | Nov 21, 2005 | Issued |
Array
(
[id] => 4663059
[patent_doc_number] => 20080253966
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-16
[patent_title] => 'Diagnostic, Prognostic, and Therapeutic Factor Smac/Diablo in Human Cancer'
[patent_app_type] => utility
[patent_app_number] => 11/667514
[patent_app_country] => US
[patent_app_date] => 2005-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 25140
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0253/20080253966.pdf
[firstpage_image] =>[orig_patent_app_number] => 11667514
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/667514 | Diagnostic, Prognostic, and Therapeutic Factor Smac/Diablo in Human Cancer | Nov 17, 2005 | Abandoned |
Array
(
[id] => 5726376
[patent_doc_number] => 20060057136
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-16
[patent_title] => 'Immunotherapy of B-Cell malignancies using anti-CD22 antibodies'
[patent_app_type] => utility
[patent_app_number] => 11/254754
[patent_app_country] => US
[patent_app_date] => 2005-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10920
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0057/20060057136.pdf
[firstpage_image] =>[orig_patent_app_number] => 11254754
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/254754 | Immunotherapy of B-cell malignancies using anti-CD22 antibodies | Oct 20, 2005 | Issued |
Array
(
[id] => 4675657
[patent_doc_number] => 20080213286
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-04
[patent_title] => 'Mam Domain Containing Protein'
[patent_app_type] => utility
[patent_app_number] => 11/577443
[patent_app_country] => US
[patent_app_date] => 2005-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 29414
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0213/20080213286.pdf
[firstpage_image] =>[orig_patent_app_number] => 11577443
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/577443 | Mam Domain Containing Protein | Oct 17, 2005 | Abandoned |
Array
(
[id] => 232626
[patent_doc_number] => 07598051
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-10-06
[patent_title] => 'Compositions and methods for the therapy and diagnosis of ovarian cancer'
[patent_app_type] => utility
[patent_app_number] => 11/250759
[patent_app_country] => US
[patent_app_date] => 2005-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46302
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/598/07598051.pdf
[firstpage_image] =>[orig_patent_app_number] => 11250759
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/250759 | Compositions and methods for the therapy and diagnosis of ovarian cancer | Oct 13, 2005 | Issued |
Array
(
[id] => 817234
[patent_doc_number] => 07411042
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-08-12
[patent_title] => 'Tumor associated nucleic acids and uses therefor'
[patent_app_type] => utility
[patent_app_number] => 11/240341
[patent_app_country] => US
[patent_app_date] => 2005-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23520
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/411/07411042.pdf
[firstpage_image] =>[orig_patent_app_number] => 11240341
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/240341 | Tumor associated nucleic acids and uses therefor | Sep 29, 2005 | Issued |
Array
(
[id] => 4515816
[patent_doc_number] => 07910704
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-03-22
[patent_title] => 'Human p53 splice variant displaying differential transcriptional activity'
[patent_app_type] => utility
[patent_app_number] => 11/236014
[patent_app_country] => US
[patent_app_date] => 2005-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 13043
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/910/07910704.pdf
[firstpage_image] =>[orig_patent_app_number] => 11236014
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/236014 | Human p53 splice variant displaying differential transcriptional activity | Sep 26, 2005 | Issued |
Array
(
[id] => 5880516
[patent_doc_number] => 20060029598
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-09
[patent_title] => 'Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions'
[patent_app_type] => utility
[patent_app_number] => 11/236059
[patent_app_country] => US
[patent_app_date] => 2005-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 6190
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20060029598.pdf
[firstpage_image] =>[orig_patent_app_number] => 11236059
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/236059 | Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions | Sep 25, 2005 | Issued |
Array
(
[id] => 5297135
[patent_doc_number] => 20090012061
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-08
[patent_title] => 'A Method of Treating Cancer'
[patent_app_type] => utility
[patent_app_number] => 11/662396
[patent_app_country] => US
[patent_app_date] => 2005-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16679
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0012/20090012061.pdf
[firstpage_image] =>[orig_patent_app_number] => 11662396
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/662396 | A Method of Treating Cancer | Sep 8, 2005 | Abandoned |
Array
(
[id] => 4663124
[patent_doc_number] => 20080254031
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-16
[patent_title] => 'Tumor Specific Genes and Variant Rnas and Uses Thereof as Targets for Cancer Therapy and Diagnosis'
[patent_app_type] => utility
[patent_app_number] => 11/575032
[patent_app_country] => US
[patent_app_date] => 2005-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 25490
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20080254031.pdf
[firstpage_image] =>[orig_patent_app_number] => 11575032
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/575032 | Tumor Specific Genes and Variant Rnas and Uses Thereof as Targets for Cancer Therapy and Diagnosis | Sep 6, 2005 | Abandoned |
Array
(
[id] => 6930780
[patent_doc_number] => 20050281814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-22
[patent_title] => 'Combination radiation therapy and chemotherapy in conjunction with administration of growth factor receptor antibody'
[patent_app_type] => utility
[patent_app_number] => 11/206825
[patent_app_country] => US
[patent_app_date] => 2005-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4008
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20050281814.pdf
[firstpage_image] =>[orig_patent_app_number] => 11206825
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/206825 | Combination radiation therapy and chemotherapy in conjunction with administration of growth factor receptor antibody | Aug 18, 2005 | Abandoned |